Richard Slayman, 62, underwent the four-hour procedure on March 16 as a treatment for end-stage kidney disease. The pig kidney, provided by Cambridge, Mass.-based eGenesis, contained 69 genomic edits to improve its compatibility with humans.
The procedure marks a historical milestone in the field of xenotransplantation and could offer a potential solution to the global organ shortage, according to Massachusetts General.
“Our hope is that this transplant approach will offer a lifeline to millions of patients worldwide who are suffering from kidney failure,” Tatsuo Kawai, MD, PhD, director of Massachusetts General’s Legorreta Center for Clinical Transplant Tolerance, said in a news release.
Mr. Slayman is recovering well and expected to be discharged from the hospital soon, the hospital said.
Learn more here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.